Clinicians tend to view obesity as a disease, while members of the body positivity movement value their bodies as they are. Should clinicians treat obesity as a disease in patients who don’t see themselves as ill?
AMA J Ethics. 2018;20(12):E1195-1200. doi:
10.1001/amajethics.2018.1195.
Haley Moulton, Benjamin Moulton, JD, MPH, Tim Lahey, MD, MMSc, and Glyn Elwyn, MD, PhD, MSc
Shared decision making in research informed consent conversations is complex due to diverse and potentially divergent interests of investigators and patient-subjects.
AMA J Ethics. 2020;22(5):E365-371. doi:
10.1001/amajethics.2020.365.
Mortality rates for breast cancer are higher where treatments are unavailable and unaffordable. Though less effective, breast examination could be a good screening approach.
AMA J Ethics. 2020;22(2):E93-101. doi:
10.1001/amajethics.2020.93.
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022;24(4):E319-325. doi:
10.1001/amajethics.2022.319.